PAHC: Phibro Animal Health Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 520.07
Enterprise Value ($M) 961.99
Book Value ($M) 270.80
Book Value / Share 6.69
Price / Book 1.92
NCAV ($M) -115.32
NCAV / Share -2.85
Price / NCAV -4.51

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.06

Liquidity (mrq)
Quick Ratio 1.60
Current Ratio 3.12

Balance Sheet (mrq) ($M)
Current Assets 586.59
Assets 972.71
Liabilities 701.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 977.89
Operating Income 71.85
Net Income 32.61
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 13.31
Cash from Investing -74.02
Cash from Financing 26.99

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13D/A BFI Co., LLC 49.90 0.00
02-13 13G/A Vanguard Group Inc 8.84 -23.87
02-08 13G Pzena Investment Management Llc 9.80 -2.57
01-19 13G/A BlackRock Inc. 18.00 0.12
01-10 13G Brandes Investment Partners, Lp 10.48 4.44

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 5,559 50,287 11.05
2024-03-26 16,460 112,227 14.67
2024-03-25 19,091 118,460 16.12
2024-03-22 9,800 92,682 10.57

(click for more detail)

Similar Companies
OCS – Oculis Holding AG OCUL – Ocular Therapeutix, Inc.
OMER – Omeros Corporation PROC – Procaps Group S.A.
PTGX – Protagonist Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io